Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025)
Elutia (ELUT) reported Liabilities from Discontinued Operations of 357000.0 for Q3 2025, up 13.33% sequentially from 315000.0 in Q4 2024.
Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends
Elutia (ELUT) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 357000.0 in Q3 2025.
- For the quarter ending Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 357000.0; the trailing twelve-month figure through Sep 2025 stood at 357000.0 (changed N/A YoY), and the FY2024 full-year result was 315000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations grew to 357000.0 in Q3 2025, from 315000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 4929000.0 in Q4 2022 to a low of 315000.0 in Q4 2024.
- A 4-year average of 2197750.0 and a median of 1773500.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Dec 31, 2024 | 315,000.00 |
| Dec 31, 2024 | 315,000.00 |
| Sep 30, 2023 | 3.19 Mn |
| Sep 30, 2023 | 3.19 Mn |
| Dec 31, 2022 | 4.93 Mn |
| Dec 31, 2022 | 4.93 Mn |